These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434 [TBL] [Abstract][Full Text] [Related]
4. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling. Cho HJ; Jin SM; Youn HD; Huh K; Mook-Jung I Aging Cell; 2008 Mar; 7(2):137-47. PubMed ID: 18081741 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease. Rossner S; Sastre M; Bourne K; Lichtenthaler SF Prog Neurobiol; 2006 Jun; 79(2):95-111. PubMed ID: 16904810 [TBL] [Abstract][Full Text] [Related]
6. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1. Clarimón J; Bertranpetit J; Calafell F; Boada M; Tàrraga L; Comas D J Neurol; 2003 Aug; 250(8):956-61. PubMed ID: 12928915 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer's disease-relevant genes and proteins. Zuchner T; Schliebs R; Perez-Polo JR J Neurochem; 2005 Oct; 95(1):20-32. PubMed ID: 16181410 [TBL] [Abstract][Full Text] [Related]
8. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent. Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807 [TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens. Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567 [TBL] [Abstract][Full Text] [Related]
10. A strategy focused on MAPT, APP, NCSTN and BACE1 to build blood classifiers for Alzheimer's disease. Herrera-Rivero M; Elena Hernández-Aguilar M; Emiliano Aranda-Abreu G J Theor Biol; 2015 Jul; 376():32-8. PubMed ID: 25863267 [TBL] [Abstract][Full Text] [Related]
11. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice. Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes. Sterniczuk R; Dyck RH; Laferla FM; Antle MC Brain Res; 2010 Aug; 1348():139-48. PubMed ID: 20471965 [TBL] [Abstract][Full Text] [Related]
14. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Bettens K; Brouwers N; Engelborghs S; Van Miegroet H; De Deyn PP; Theuns J; Sleegers K; Van Broeckhoven C Hum Mutat; 2009 Aug; 30(8):1207-13. PubMed ID: 19462468 [TBL] [Abstract][Full Text] [Related]
15. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. Sun X; He G; Song W FASEB J; 2006 Jul; 20(9):1369-76. PubMed ID: 16816112 [TBL] [Abstract][Full Text] [Related]
16. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease. Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871 [TBL] [Abstract][Full Text] [Related]
17. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model. Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646 [TBL] [Abstract][Full Text] [Related]
18. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker? Lee J; Ryu H BMB Rep; 2010 Oct; 43(10):649-55. PubMed ID: 21034526 [TBL] [Abstract][Full Text] [Related]
20. Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease. Walker MP; LaFerla FM; Oddo SS; Brewer GJ Age (Dordr); 2013 Jun; 35(3):519-31. PubMed ID: 22237558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]